1. Antibacterials

   Case report 17 September 2022 Pages: 51 - 51

2. Antibacterials/antineoplastics/steroids

   Case report 17 September 2022 Pages: 52 - 52

3. Antibacterials/antineoplastics/vasopressors

   Case report 17 September 2022 Pages: 53 - 53

4. Antibacterials/antivirals/dexamethasone

   Case report 17 September 2022 Pages: 54 - 54

5. Antibacterials/dexamethasone/methylprednisolone

   Case report 17 September 2022 Pages: 55 - 55

6. Antibacterials/durvalumab

   Case report 17 September 2022 Pages: 56 - 56

7. Antibacterials/immunosuppressants

   Case report 17 September 2022 Pages: 57 - 57

8. Antibacterials/paracetamol

   Case report 17 September 2022 Pages: 58 - 58

9. Antibiotics

   Case report 17 September 2022 Pages: 59 - 59

10. Antidepressants/gastrokinetics/uncaria tomentosa

    Case report 17 September 2022 Pages: 60 - 60

11. Antidiabetics

    Case report 17 September 2022 Pages: 61 - 61

12. Antiepileptic-drugs

    Case report 17 September 2022 Pages: 62 - 62

13. Antiepileptic-drugs/immunosuppressants

    Case report 17 September 2022 Pages: 63 - 63

14. Antihypertensives/nitroglycerin

    Case report 17 September 2022 Pages: 64 - 64

15. Antineoplastics

    Case report 17 September 2022 Pages: 65 - 65

16. Antineoplastics

    Case report 17 September 2022 Pages: 66 - 66

17. Antineoplastics

    Case report 17 September 2022 Pages: 67 - 67

18. Antineoplastics

    Case report 17 September 2022 Pages: 68 - 68

19. Antineoplastics

    Case report 17 September 2022 Pages: 69 - 69

20. Antineoplastics

    Case report 17 September 2022 Pages: 70 - 70

21. Antineoplastics

    Case report 17 September 2022 Pages: 71 - 71

22. Antineoplastics

    Case report 17 September 2022 Pages: 72 - 72

23. Antineoplastics

    Case report 17 September 2022 Pages: 73 - 73

24. Antineoplastics

    Case report 17 September 2022 Pages: 74 - 74

25. Antineoplastics

    Case report 17 September 2022 Pages: 75 - 75

26. Antineoplastics

    Case report 17 September 2022 Pages: 76 - 76

27. Antineoplastics

    Case report 17 September 2022 Pages: 77 - 77

28. Antineoplastics

    Case report 17 September 2022 Pages: 78 - 78

29. Antineoplastics/folinic-acid

    Case report 17 September 2022 Pages: 79 - 79

30. Antineoplastics/unspecified immune checkpoint protein inhibitors

    Case report 17 September 2022 Pages: 80 - 80

31. Antiparkinsonians/elasomeran/tozinameran

    Case report 17 September 2022 Pages: 81 - 81

32. Antipsychotics

    Case report 17 September 2022 Pages: 82 - 82

33. Antithymocyte-globulin/mycophenolate/prednisone/tacrolimus

    Case report 17 September 2022 Pages: 83 - 83

34. Antithymocyte-globulin/prednisone/tacrolimus

    Case report 17 September 2022 Pages: 84 - 84

35. Antituberculars

    Case report 17 September 2022 Pages: 85 - 85

36. Apixaban/aspirin

    Case report 17 September 2022 Pages: 86 - 86

37. Apixaban/enoxaparin-sodium

    Case report 17 September 2022 Pages: 87 - 87

38. Aprotinin/gelatin

    Case report 17 September 2022 Pages: 88 - 88

39. Aripiprazole

    Case report 17 September 2022 Pages: 89 - 89

40. Arsenic trioxide

    Case report 17 September 2022 Pages: 90 - 90

41. Artesunate

    Case report 17 September 2022 Pages: 91 - 91

42. Aspirin/ciclosporin/infliximab

    Case report 17 September 2022 Pages: 92 - 92

43. Atezolizumab/bevacizumab/carboplatin/paclitaxel

    Case report 17 September 2022 Pages: 93 - 93

44. Atezolizumab/nivolumab/pembrolizumab

    Case report 17 September 2022 Pages: 94 - 94

45. Atropine

    Case report 17 September 2022 Pages: 95 - 95

46. Axicabtagene-ciloleucel

    Case report 17 September 2022 Pages: 96 - 96

47. Axicabtagene-ciloleucel/brexucabtagene-autoleucel/tisagenlecleucel

    Case report 17 September 2022 Pages: 97 - 97

48. Azathioprine

    Case report 17 September 2022 Pages: 98 - 98

49. Azathioprine

    Case report 17 September 2022 Pages: 99 - 99

50. Azathioprine

    Case report 17 September 2022 Pages: 100 - 100